动脉「炎性衰老」驱动透析儿童血管钙化
透析儿童心血管死亡风险相当于普通老年人群,并快速出现内侧血管钙化。研究假设晚期CKD儿童存在早衰并促进钙化。结果显示透析儿童血管氧化DNA损伤增加、衰老标志物p16和p21升高,血管平滑肌细胞DNA损伤修复受损并加速衰老,钙化条件下成骨分化和钙化增加,与SASP激活相关;阻断ATM介导的DNA损伤信号可减少炎症和钙化。
要点
- 透析儿童血管存在氧化DNA损伤和衰老标志物p16、p21升高。
- 血管平滑肌细胞DNA损伤修复受损、加速衰老,促进成骨分化和钙化。
- 阻断ATM介导的DNA损伤信号可减少炎症和钙化。
核心结论
- 晚期CKD儿童存在血管早衰,透析儿童更明显,表现为氧化DNA损伤、衰老标志物升高和SASP激活。
- 失调的矿物质代谢通过促进氧化DNA损伤、早衰和促炎SASP驱动血管「炎性衰老」,进而促进血管钙化。
- 靶向DNA损伤信号或清除衰老细胞的药物可能预防晚期CKD患者血管钙化。
研究设计与样本
- 研究对比透析与非透析的5期CKD儿童血管组织,并以健康对照作参照。
- 体外用钙化培养基处理血管环,并培养透析儿童血管平滑肌细胞。
- 临床分析透析儿童循环SASP因子与血管僵硬度和冠状动脉钙化的相关性。
主要发现
- 5期CKD儿童血管(伴或不伴透析)存在氧化DNA损伤增加。
- 透析儿童血管p16和p21升高;钙化培养基增加5期CKD儿童血管环氧化DNA损伤,健康对照无此变化。
- 透析儿童血管平滑肌细胞持续DNA损伤、DNA损伤修复受损并加速衰老,钙化条件下成骨分化和钙化增加。
- 上述变化与SASP激活相关;阻断ATM介导的DNA损伤信号减少炎症和钙化。
- 透析儿童循环成骨性SASP因子升高,与血管僵硬度和冠状动脉钙化增加相关。
临床怎么用
- 对透析儿童应关注血管钙化和心血管风险,可考虑评估血管僵硬度和冠状动脉钙化。
- 靶向DNA损伤信号或清除衰老细胞是潜在预防血管钙化的策略,尚需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Children on dialysis have a cardiovascular mortality risk equivalent to older adults in the general population, and rapidly develop medial vascular calcification, an age-associated pathology. We hypothesized that premature vascular ageing contributes to calcification in children with advanced chronic kidney disease (CKD). Vessels from children with Stage 5 CKD with and without dialysis had evidence of increased oxidative DNA damage. The senescence markers p16 and p21 were also increased in vessels from children on dialysis. Treatment of vessel rings ex vivo with calcifying media increased oxidative DNA damage in vessels from children with Stage 5 CKD, but not in those from healthy controls. Vascular smooth muscle cells cultured from children on dialysis exhibited persistent DNA damage, impaired DNA damage repair, and accelerated senescence. Under calcifying conditions vascular smooth muscle cells from children on dialysis showed increased osteogenic differentiation and calcification. These changes correlated with activation of the senescence-associated secretory phenotype (SASP), an inflammatory phenotype characterized by the secretion of proinflammatory cytokines and growth factors. Blockade of ataxia-telangiectasia mutated (ATM)-mediated DNA damage signaling reduced both inflammation and calcification. Clinically, children on dialysis had elevated circulating levels of osteogenic SASP factors that correlated with increased vascular stiffness and coronary artery calcification. These data imply that dysregulated mineral metabolism drives vascular "inflammaging" by promoting oxidative DNA damage, premature senescence, and activation of a pro-inflammatory SASP. Drugs that target DNA damage signaling or eliminate senescent cells may have the potential to prevent vascular calcification in patients with advanced CKD.
引用
- Sanchis P, Ho CY, Liu Y, et al. Arterial "inflammaging" drives vascular calcification in children on dialysis. Kidney Int. 2019. PMID: 30827513. doi:10.1016/j.kint.2018.12.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。